Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Transtema in connection with listing on Nasdaq Stockholm
Mandate

Vinge advises Transtema in connection with listing on Nasdaq Stockholm

September 17, 2021 Banking and Finance Capital Markets and Public M&A Employment and Benefits Intellectual Property IT, Telecommunications and Outsourcing

Vinge has advised Transtema in connection with its application for admission to trading on Nasdaq Stockholm’s main list.

The Nasdaq Companies Committee approved the application on 17 September 2021, and Transtema published the prospectus on the same day. The first day of trading is planned to take place on 29 September.

Vinge’s team primarily consisted of Anders Strid, Edin Agic (Project Manager), Jacob Benzov, Lina André (Banking and Finance), Anna Backman (Employment Law), Alexander Lindeberg (IP/IT) and Anna Högsten (IP/IT)

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025